{"id":"https://openalex.org/W2524344698","doi":"https://doi.org/10.1136/annrheumdis-2016-209668","title":"Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial","display_name":"Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial","publication_year":2016,"publication_date":"2016-09-27","ids":{"openalex":"https://openalex.org/W2524344698","doi":"https://doi.org/10.1136/annrheumdis-2016-209668","mag":"2524344698","pmid":"https://pubmed.ncbi.nlm.nih.gov/27672124","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5446001"},"language":"en","primary_location":{"id":"doi:10.1136/annrheumdis-2016-209668","doi":"https://doi.org/10.1136/annrheumdis-2016-209668","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2016-209668","pdf_url":"https://ard.bmj.com/content/annrheumdis/76/3/534.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://ard.bmj.com/content/annrheumdis/76/3/534.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071430304","display_name":"Daniel J. Wallace","orcid":"https://orcid.org/0000-0002-2502-1372","observed_orcids":["https://orcid.org/0000-0002-2502-1372"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel J Wallace","raw_affiliation_strings":["Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA","Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA","institution_ids":["https://openalex.org/I1282927834"]},{"raw_affiliation_string":"Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012283576","display_name":"Vibeke Strand","orcid":"https://orcid.org/0000-0003-4978-4072","observed_orcids":["https://orcid.org/0000-0003-4978-4072"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vibeke Strand","raw_affiliation_strings":["Division of Immunology/Rheumatology, Stanford University, Palo Alto, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Immunology/Rheumatology, Stanford University, Palo Alto, California, USA","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052053321","display_name":"Joan T. Merrill","orcid":"https://orcid.org/0000-0002-4514-2382","observed_orcids":["https://orcid.org/0000-0002-4514-2382","https://orcid.org/0000-0002-9205-940X"]},"institutions":[{"id":"https://openalex.org/I30558944","display_name":"Oklahoma Medical Research Foundation","ror":"https://ror.org/035z6xf33","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I30558944"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joan T Merrill","raw_affiliation_strings":["Department of Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA","institution_ids":["https://openalex.org/I30558944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060272056","display_name":"Serghei Popa","orcid":"https://orcid.org/0000-0001-9348-4187","observed_orcids":["https://orcid.org/0000-0001-9348-4187"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Serghei Popa","raw_affiliation_strings":["Republican Clinical Hospital, Chisinau, Moldova"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Republican Clinical Hospital, Chisinau, Moldova","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089331247","display_name":"Alberto J. Spindler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alberto J Spindler","raw_affiliation_strings":["Centro Medico Privado de Reumatologia, Tucuman, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Medico Privado de Reumatologia, Tucuman, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086632584","display_name":"Alicia Eimon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139031","display_name":"Centro de Educaci\u00f3n M\u00e9dica e Investigaciones Cl\u00ednicas Norberto Quirno","ror":"https://ror.org/04czhsq43","country_code":"AR","type":"nonprofit","lineage":["https://openalex.org/I4210139031"]}],"countries":["AR"],"is_corresponding":false,"raw_author_name":"Alicia Eimon","raw_affiliation_strings":["CEMIC, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CEMIC, Buenos Aires, Argentina","institution_ids":["https://openalex.org/I4210139031"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082713013","display_name":"Michelle Petri","orcid":"https://orcid.org/0000-0003-1441-5373","observed_orcids":["https://orcid.org/0000-0003-1441-5373"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Petri","raw_affiliation_strings":["Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University School of Medicine, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111657027","display_name":"Josef S Smolen","orcid":"https://orcid.org/0000-0002-8899-9087","observed_orcids":["https://orcid.org/0000-0002-8899-9087"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Josef S Smolen","raw_affiliation_strings":["Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria"],"raw_orcid":"https://orcid.org/0000-0002-8899-9087","affiliations":[{"raw_affiliation_string":"Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038128984","display_name":"Joseph S. Wajdula","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Wajdula","raw_affiliation_strings":["Pfizer Inc, Collegeville, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Collegeville, Pennsylvania, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jared Christensen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jared Christensen","raw_affiliation_strings":["Pfizer Inc, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039066645","display_name":"Cheryl Li","orcid":"https://orcid.org/0009-0009-5615-8046","observed_orcids":["https://orcid.org/0009-0009-5615-8046"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cheryl Li","raw_affiliation_strings":["Pfizer Inc, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110557200","display_name":"Annette M. Diehl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Annette Diehl","raw_affiliation_strings":["Pfizer Inc, Collegeville, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Collegeville, Pennsylvania, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082823681","display_name":"Michael S. Vincent","orcid":"https://orcid.org/0000-0001-9569-4284","observed_orcids":["https://orcid.org/0000-0001-9569-4284"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael S Vincent","raw_affiliation_strings":["Pfizer Inc, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090265370","display_name":"JEAN SACCUZZO BEEBE","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jean Beebe","raw_affiliation_strings":["Pfizer Inc, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018778029","display_name":"Paul J. Healey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Healey","raw_affiliation_strings":["Pfizer Inc, Groton, Connecticut, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc, Groton, Connecticut, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113677709","display_name":"Sudhakar Sridharan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1296342797","display_name":"Pharmaceutical Product Development (United States)","ror":"https://ror.org/01sjx9496","country_code":"US","type":"company","lineage":["https://openalex.org/I1296342797"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sudhakar Sridharan","raw_affiliation_strings":["PPD Inc, Rockville, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PPD Inc, Rockville, Maryland, USA","institution_ids":["https://openalex.org/I1296342797"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5071430304"],"corresponding_institution_ids":["https://openalex.org/I1282927834"],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":{"value":4870,"currency":"USD","value_usd":4870},"fwci":11.0787,"has_fulltext":true,"cited_by_count":137,"citation_normalized_percentile":{"value":0.98930434,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"76","issue":"3","first_page":"534","last_page":"542"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.9890000224113464},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.871999979019165},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8809999823570251},{"id":"https://openalex.org/keywords/dose-ranging-study","display_name":"dose-ranging","score":0.7540000081062317},{"id":"https://openalex.org/keywords/sle-responder-index","display_name":"SLE Responder Index","score":0.7789999842643738},{"id":"https://openalex.org/keywords/disease-flares","display_name":"disease flares","score":0.828000009059906},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.6179999709129333},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8840000033378601},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.597000002861023}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9346311688423157},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7500567436218262},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6932022571563721},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5793541669845581},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5616311430931091},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5335932970046997},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5292187333106995},{"id":"https://openalex.org/C2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","level":3,"score":0.5275970101356506},{"id":"https://openalex.org/C2776312127","wikidata":"https://www.wikidata.org/wiki/Q5299247","display_name":"Dose-ranging study","level":5,"score":0.5044652223587036},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.4952344000339508},{"id":"https://openalex.org/C2775915377","wikidata":"https://www.wikidata.org/wiki/Q188297","display_name":"Lupus erythematosus","level":3,"score":0.43327248096466064},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.4190356135368347},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.34046292304992676},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3342750668525696},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.29296499490737915},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.21086105704307556},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.109477698802948},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08758527040481567},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.07470861077308655},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000067251","descriptor_name":"Symptom Flare Up","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093242","descriptor_name":"Interleukin-6 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006261","descriptor_name":"Headache","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D011655","descriptor_name":"Pulmonary Embolism","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018805","descriptor_name":"Sepsis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1136/annrheumdis-2016-209668","doi":"https://doi.org/10.1136/annrheumdis-2016-209668","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2016-209668","pdf_url":"https://ard.bmj.com/content/annrheumdis/76/3/534.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4313082","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5446001","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5446001","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5446001","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ann Rheum Dis","raw_type":"Text"},{"id":"pmid:27672124","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27672124","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the rheumatic diseases","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:ibn.idsi.md:158526","doi":null,"is_oa":true,"landing_page_url":"https://ibn.idsi.md/vizualizare_articol/158526","pdf_url":null,"source":null,"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Annals of the Rheumatic Diseases 534-542","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:open-archive.highwire.org:annrheumdis:76/3/534","doi":null,"is_oa":false,"landing_page_url":"http://ard.bmj.com/cgi/content/short/76/3/534","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":{"id":"doi:10.1136/annrheumdis-2016-209668","doi":"https://doi.org/10.1136/annrheumdis-2016-209668","is_oa":true,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2016-209668","pdf_url":"https://ard.bmj.com/content/annrheumdis/76/3/534.full.pdf","source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308604","display_name":"Biogen","ror":"https://ror.org/02jqkb192"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320315421","display_name":"Anthera","ror":"https://ror.org/04pa38t98"},{"id":"https://openalex.org/F4320322202","display_name":"IC Design Education Center","ror":"https://ror.org/005v57z85"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320332200","display_name":"EMD Serono","ror":"https://ror.org/027zrs220"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2524344698.pdf","grobid_xml":"https://content.openalex.org/works/W2524344698.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W1537631996","https://openalex.org/W1840567140","https://openalex.org/W1920228500","https://openalex.org/W1966335538","https://openalex.org/W1974228640","https://openalex.org/W1981529343","https://openalex.org/W2004488054","https://openalex.org/W2016318369","https://openalex.org/W2023042240","https://openalex.org/W2025492877","https://openalex.org/W2026527144","https://openalex.org/W2043298079","https://openalex.org/W2061921891","https://openalex.org/W2065400561","https://openalex.org/W2096286605","https://openalex.org/W2097165105","https://openalex.org/W2102010541","https://openalex.org/W2105866978","https://openalex.org/W2111416025","https://openalex.org/W2119296184","https://openalex.org/W2124661298","https://openalex.org/W2131457901","https://openalex.org/W2131469748","https://openalex.org/W2135392289","https://openalex.org/W2136149088","https://openalex.org/W2141603878","https://openalex.org/W2147495692","https://openalex.org/W2154831555","https://openalex.org/W2154891290","https://openalex.org/W2155779547","https://openalex.org/W2158592788","https://openalex.org/W2308059048","https://openalex.org/W2317247348","https://openalex.org/W2412228566","https://openalex.org/W2615066072"],"related_works":["https://openalex.org/W2328268687","https://openalex.org/W2973404796","https://openalex.org/W4395701175","https://openalex.org/W4402562191","https://openalex.org/W4291993884","https://openalex.org/W2308059048","https://openalex.org/W2136149088","https://openalex.org/W4284672782","https://openalex.org/W1679569810","https://openalex.org/W4297200062"],"abstract_inverted_index":{"OBJECTIVES:":[0],"This":[1],"phase":[2],"II":[3],"trial":[4],"evaluated":[5],"the":[6,112,130,170,215,248],"efficacy":[7,114,217],"and":[8,55,108,152,173,204],"safety":[9,106,256],"of":[10,142,225],"an":[11,74,226],"interleukin":[12],"(IL)":[13],"6":[14],"monoclonal":[15],"antibody":[16],"for":[17,123,136,214,241],"systemic":[18],"lupus":[19],"erythematosus":[20],"(SLE).":[21],"METHODS:":[22],"Patients":[23],"with":[24,44,127,148,163,181,222,228],"active":[25],"disease":[26,166],"were":[27,65,120,178],"randomised":[28],"to":[29,105,244,255],"placebo":[30,158,213],"or":[31,37],"PF-04236921":[32,207],"10":[33,89,137,149,182,191,229],"mg,":[34,39,90,93,96,189,192],"50":[35,92,153,245],"mg":[36,100,138,150,154,183,230,246,250],"200":[38,95,99,249],"subcutaneously,":[40],"every":[41],"8":[42],"weeks":[43],"stable":[45],"background":[46],"therapy.":[47],"SLE":[48],"Responder":[49],"Index":[50],"(SRI-4;":[51],"primary":[52,113,216],"end":[53,218],"point)":[54],"British":[56],"Isles":[57],"Lupus":[58,62],"Assessment":[59,63],"Group-based":[60],"Composite":[61],"(BICLA)":[64],"assessed":[66],"at":[67],"week":[68],"24.":[69],"Post":[70],"hoc":[71,236],"analysis":[72],"identified":[73],"enriched":[75],"population":[76],"based":[77],"upon":[78],"planned":[79],"univariate":[80],"analyses.":[81],"RESULTS:":[82],"183":[83],"patients":[84,162,221],"received":[85],"treatment":[86],"(placebo,":[87],"n=45;":[88,91],"n=47;":[94],"n=46).":[97],"The":[98,116,140,195],"dose":[101,125,251],"was":[102,134,145,208,231,239,252],"discontinued":[103,253],"due":[104,254],"findings":[107],"not":[109,121,209],"included":[110,201],"in":[111,220,233],"analysis.":[115,237],"SRI-4":[117,171],"response":[118,132,176],"rates":[119,177],"significant":[122,135],"any":[124],"compared":[126],"placebo;":[128],"however,":[129],"BICLA":[131,174],"rate":[133],"(p=0.026).":[139],"incidence":[141],"severe":[143],"flares":[144],"significantly":[146,179,210],"reduced":[147],"(n=0)":[151],"(n=2)":[155],"combined":[156],"versus":[157,184],"(n=8;":[159],"p<0.01).":[160],"In":[161],"greater":[164],"baseline":[165],"activity":[167],"(enriched":[168],"population),":[169],"(p=0.004)":[172],"(p=0.012)":[175],"different":[180,211],"placebo.":[185],"Four":[186],"deaths":[187],"(200":[188],"n=3;":[190],"n=1)":[193],"occurred.":[194],"most":[196],"frequently":[197],"reported":[198],"adverse":[199],"events":[200],"headache,":[202],"nausea":[203],"diarrhoea.":[205],"CONCLUSIONS:":[206],"from":[212],"point":[219],"SLE.":[223],"Evidence":[224],"effect":[227],"seen":[232],"a":[234],"post":[235],"Safety":[238],"acceptable":[240],"doses":[242],"up":[243],"as":[247],"findings.":[257],"TRIAL":[258],"REGISTRATION":[259],"NUMBER:":[260],"NCT01405196;":[261],"Pre-results.":[262]},"counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":18},{"year":2021,"cited_by_count":21},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":20},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-10-07T00:00:00"}